These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 25224767)
1. Fatty liver-induced changes in stereotypic behavior in rats and effects of glucagon-like peptide-1 analog on stereotypy. Erbaş O; Akseki HS; Solmaz V; Aktuğ H; Taşkıran D Kaohsiung J Med Sci; 2014 Sep; 30(9):447-52. PubMed ID: 25224767 [TBL] [Abstract][Full Text] [Related]
2. Detection of impaired cognitive function in rat with hepatosteatosis model and improving effect of GLP-1 analogs (exenatide) on cognitive function in hepatosteatosis. Erbaş O; Sarac F; Aktuğ H; Peker G ScientificWorldJournal; 2014; 2014():946265. PubMed ID: 24741367 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson's Disease. Aksoy D; Solmaz V; Çavuşoğlu T; Meral A; Ateş U; Erbaş O Am J Med Sci; 2017 Sep; 354(3):319-324. PubMed ID: 28918840 [TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [TBL] [Abstract][Full Text] [Related]
10. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984 [TBL] [Abstract][Full Text] [Related]
11. Exenatide improves hypertension in a rat model of the metabolic syndrome. Laugero KD; Stonehouse AH; Guss S; Landry J; Vu C; Parkes DG Metab Syndr Relat Disord; 2009 Aug; 7(4):327-34. PubMed ID: 19320558 [TBL] [Abstract][Full Text] [Related]
12. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY; Pan JQ; Lv JH Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135 [TBL] [Abstract][Full Text] [Related]
13. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c. Zhang J; Tan Y; Yao F; Zhang Q Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825 [TBL] [Abstract][Full Text] [Related]
15. Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells. Chang G; Zhang D; Liu J; Zhang P; Ye L; Lu K; Duan Q; Zheng A; Qin S Exp Biol Med (Maywood); 2014 Apr; 239(4):414-22. PubMed ID: 24586099 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of exenatide against oxidative stress-induced injury. Chang G; Zhang D; Yu H; Zhang P; Wang Y; Zheng A; Qin S Int J Mol Med; 2013 Nov; 32(5):1011-20. PubMed ID: 23982489 [TBL] [Abstract][Full Text] [Related]
18. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Hong XZ; Li LD; Wu LM Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732 [TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats. Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]